METOJECT
50MG/ML INJ SOL ISP 5X0,30ML+J II
Marketing authorisation holder has not reported any information about availability on the market.
50MG/ML INJ SOL ISP 5X0,30ML+J II
Marketing authorisation holder has not reported any information about availability on the market.
2010 © SÚKL. Šrobárova 48, 100 41 Praha 10, +420 272 185 111, posta@suklcz.